PORTAL HYPERTENSION-Assessment of surgical risks:
The presence of clinically significant portal hypertension (CSPH), determined either by HVPG ≥10 mmHg or by clinical manifestations of portal hypertension, is associated with a higher risk of decompensation and mortality in patients with cirrhosis undergoing liver resection for hepatocellular carcinoma (HCC).
In candidates for non-hepatic abdominal surgery, a HVPG ≥16 mmHg is associated with an increased risk of short-term mortality after surgery.
Corrigendum to ‘Baveno VII – Renewing consensus in portal hypertension’ [J Hepatol (2022) 959-974] Journal of Hepatology, Vol. 77, Issue 2